Charite - University Medicine Berlin: Cystic Fibrosis - Increasing Numbers of Patients Benefit From Improved Treatment
August 27, 2021
August 27, 2021
BERLIN, Germany, Aug. 27 (TNSJou) -- Charite - University Medicine Berlin issued the following news:
A clinical trial, conducted by an international team of researchers and co-led by Charite - Universitatsmedizin Berlin, has shown that a triple combination therapy consisting of three known compounds is both safe and effective in cystic fibrosis patients with relatively rare disease-causing genetic defects. Writing in the New England Journal of Medicine/*, the researchers predict tha . . .
A clinical trial, conducted by an international team of researchers and co-led by Charite - Universitatsmedizin Berlin, has shown that a triple combination therapy consisting of three known compounds is both safe and effective in cystic fibrosis patients with relatively rare disease-causing genetic defects. Writing in the New England Journal of Medicine/*, the researchers predict tha . . .